Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes

MLA

Andreas Spinrath, et al. “Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes.” Journal of Medicinal Chemistry, vol. 51, Oct. 2008, pp. 7061–64. EBSCOhost, https://doi.org/10.1021/jm8010178.

APA

Andreas Spinrath, Christian Urban, Andrew D. Bond, Elisabeth Christiansen, Evi Kostenis, Matthias U. Kassack, Nicole Merten, Alexandra Hamacher, Trond Ulven, Christel Drewke, Susanne Ullrich, Kasper K. Karlsen, & Kathrin Liebscher. (2008). Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes. Journal of Medicinal Chemistry, 51, 7061–7064. https://doi.org/10.1021/jm8010178

Chicago

Andreas Spinrath, Christian Urban, Andrew D. Bond, Elisabeth Christiansen, Evi Kostenis, Matthias U. Kassack, Nicole Merten, et al. 2008. “Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes.” Journal of Medicinal Chemistry 51 (October): 7061–64. doi:10.1021/jm8010178.